Perspective: Consolidation Shapes Pharma
Pharma company consolidation and outsourcing led to a de-emphasis of manufacturing and reduced investment in new technologies and facilities.
Perspective: Cost Constraints Hinder Innovation
Cheaper drugs are good for consumers, but cost restrictions limit drug company incentives to modernize facilities.
Perspective: Big Pharma No Longer the Center of Innovation
Regulations and business changes have altered Big Pharma’s place in the industry.
Perspective: Biologics Advance the Pharma Industry
Advancements in cell culture and protein technology have opened the door for new therapies.
21st-Century OSDs: Times, They Are a Changin’
Pharma’s test of continuous manufacturing is starting with oral solid-dosage forms.
Process Validation Evolution—The Lifecycle Approach
FDA’s process validation guidance has evolved and the current lifecycle approach has profoundly influenced validation practice.
40 Years of PharmTech
Pharmaceutical Technology marks 40 years of publishing.
A Question of Quality
Greater transparency and reliability of information are needed in the quality assessments of biosimilars.
Data Integrity Expectations of EU GMP Inspectors
The author reviews key technological expectations of EU GMP inspectors on the integrity of e-records.
Pharmaceutical Technology, July 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Technology July 2017 issue in an interactive PDF format.
